The current institutional shareholding score of Opus Genetics Inc is 3.00, ranking 94 out of 157 in the Pharmaceuticals industry. The latest institutional shareholding proportion is 41.70%, representing a quarter-over-quarter increase of 43.05%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.10% of shares outstanding, with 11.23% increase in holdings.